Add BrightSurf on Google Email

Blood pressure enzyme can have tumor-sensing role

Researchers found that increasing production of angiotensin-converting enzyme in macrophages enhances the immune system's ability to sense and respond to tumors. This discovery suggests a strategy for amplifying immune system function in humans, potentially enhancing cancer patients' ability to resist tumor growth.

SourceEmory Health Sciences·JournalJournal of Biological Chemistry·DateApr 7, 2008

MRI: A window to genetic properties of brain tumors

Researchers have shown that MRI can non-invasively characterize brain tumors and determine which are responsive to specific treatments based on their molecular properties. The study identified five distinct MRI features linked with particular gene expression patterns, including those associated with tumor proliferation and growth.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateMar 24, 2008

Gene plays 'Jekyll and Hyde' in brain cancer

A new study has found that a gene called STAT3 can behave differently depending on genetic nuances between individuals, playing a tumor suppressor role in some glioblastoma cases. The discovery has laid the foundation for personalized medicine approaches to treat this devastating brain cancer.

SourceHarvard Medical School·JournalGenes & Development·DateFeb 6, 2008

Combined radiation seed, chemotherapy wafer implants show promise in treating cancerous brain tumors

A study published in the Journal of Neurosurgery found that simultaneous implantation of radioactive seeds and chemotherapy wafers following surgery improved patient survival rates for recurrent glioblastoma multiforme (GBM) patients. The median survival was 69 weeks, with nearly a quarter of patients surviving two years.

SourceUniversity of Cincinnati·JournalJournal of Neurosurgery·DateJan 18, 2008

Tumor painting revolutionizes fight against cancer

Researchers developed a new cancer treatment called Chlorotoxin:Cy5.5, which can illuminate tumor cells in the operating room, making it easier for surgeons to remove all cancerous cells without injuring surrounding healthy tissue. This technology has the potential to improve cancer therapy and save lives.

SourceSeattle Children's·JournalCancer Research·DateJul 15, 2007

A genetic factor predicts prognosis in brain tumor patients

A genetic factor has been identified that predicts prognosis in brain tumor patients. The Notch2 gene is a key regulator of developmental processes and its loss positively predicts survival in subgroups of brain tumor cases. This finding offers new targets for molecular intervention to develop drugs against this severe human disease.

SourcePLOS·JournalPLOS ONE·DateJun 27, 2007